eureKING
A SPAC acquiring European biomanufacturers to create a large-scale CDMO for advanced therapies.
KINGS | PA
Overview
Corporate Details
- ISIN(s):
- FR0014009ON9
- LEI:
- 96950078TLFWTM2QE234
- Country:
- France
- Address:
- 128 RUE LA BOETIE, 75008 PARIS
- Website:
- https://eureking.com
- Sector:
- Mining and quarrying
- Industry:
- Extraction of natural gas
Description
eureKING is a Special Purpose Acquisition Company (SPAC) founded in March 2022 with the strategic objective of creating a leading European bio-Contract Development and Manufacturing Organization (CDMO). Steered by experienced biopharma executives, the company focuses on acquiring and consolidating companies within the fragmented European biomanufacturing sector. Its primary acquisition targets are businesses specializing in the production of biologics, cell and gene therapies, and other innovative biopharmaceutical products. eureKING's mission is to build a large-scale, publicly listed CDMO to serve the growing demands of the healthcare industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-28 20:03 |
Delisting Announcement
Early dissolution, leading to liquidation of eureKING, approved by the sharehol…
|
English | 314.0 KB | ||
| 2023-11-28 20:03 |
Delisting Announcement
Dissolution anticipée, entrainant la liquidation d’eureKING, approuvée par l’as…
|
French | 289.1 KB | ||
| 2023-11-24 17:50 |
Delisting Announcement
Delisting of all financial instruments issued by the Company following the extr…
|
English | 254.8 KB | ||
| 2023-11-24 17:50 |
Delisting Announcement
Radiation de la cote de l’ensemble des instruments financiers émis par la Socié…
|
French | 256.1 KB | ||
| 2023-11-06 21:14 |
Pre-Annual General Meeting Information
Availability of the preparatory documents for the shareholders’ Extraordinary G…
|
English | 219.2 KB | ||
| 2023-11-06 21:14 |
Pre-Annual General Meeting Information
Mise à disposition des documents préparatoires à l’assemblée générale extraordi…
|
French | 194.7 KB | ||
| 2023-10-12 18:56 |
M&A Activity
eureKING will not complete its Proposed acquisitions of Skyepharma and SCTbio a…
|
English | 205.4 KB | ||
| 2023-10-12 18:56 |
Delisting Announcement
eureKING annonce l’abandon de son projet d’acquisition de Skyepharma et de SCTb…
|
French | 198.7 KB | ||
| 2023-10-11 16:08 |
Major Shareholding Notification
Franchissement de seuils
|
French | 200.3 KB | ||
| 2023-10-11 16:08 |
Major Shareholding Notification
Franchissement de seuils
|
French | 200.6 KB | ||
| 2023-10-11 16:07 |
Major Shareholding Notification
Franchissement de seuils et déclaration d'intention
|
French | 353.6 KB | ||
| 2023-10-09 07:35 |
M&A Activity
Update on the Proposed IBC with Skyepharma and the Proposed Acquisition of SCTb…
|
English | 266.4 KB | ||
| 2023-10-09 07:35 |
Post-Annual General Meeting Information
Mise à jour sur l’IBC Proposé avec Skyepharma et l’Acquisition Proposée de SCTb…
|
French | 254.4 KB | ||
| 2023-10-04 08:48 |
Major Shareholding Notification
Franchissement de seuils
|
French | 198.0 KB | ||
| 2023-10-03 11:00 |
Major Shareholding Notification
Franchissement de seuils
|
French | 264.2 KB |
Automate Your Workflow. Get a real-time feed of all eureKING filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for eureKING via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
